High-resolution mapping of the X-linked lymphoproliferative syndrome region by FISH on combed DNA. 1998

K Monier, and X Michalet, and J Lamartine, and C Schurra, and F Heitzmann, and L Yin, and R Cinti, and B S Sylla, and M Creaven, and G Porta, and C Vourc'h, and M Robert-Nicoud, and A Bensimon, and G Romeo
Laboratoire DYOGEN, Unité INSERM U309, Institut Albert Bonniot, La Tronche, France. Karine.Monier@ujf-grenoble.fr

X-linked lymphoproliferative syndrome is an inherited immunodeficiency for which the responsible gene is currently unknown. Several megabase-sized deleted regions mapping to Xq25 have been identified in XLP patients, and more recently a 130-kb deletion has been reported (Lamartine et al., 1996; Lanyi et al., 1996). To establish a physical map of this deleted region and to identify the XLP gene, two cosmid contigs were established (Lamartine et al., 1996). However, the physical map of this region is still uncompleted and controversial and three points remain unsolved: (1) the centromeric-telomeric orientation of the whole region, (2) the relative orientation of the two contigs, and (3) the size of the gap between the two contigs. To provide a definitive answer to these questions, high-resolution mapping by fluorescence in situ hybridization on combed DNA and molecular approaches were combined to establish the physical map of the XLP region over 600 kb. Our results identified a gap of 150 kb between the two contigs, established the relative orientation of one contig to the other, and determine the centromeric-telomeric orientation of the whole region. Our results show that the order of the marker over this region is: cen.1D10T7-DF83-DXS982.tel.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D008297 Male Males
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes
D014960 X Chromosome The female sex chromosome, being the differential sex chromosome carried by half the male gametes and all female gametes in human and other male-heterogametic species. Chromosome, X,Chromosomes, X,X Chromosomes

Related Publications

K Monier, and X Michalet, and J Lamartine, and C Schurra, and F Heitzmann, and L Yin, and R Cinti, and B S Sylla, and M Creaven, and G Porta, and C Vourc'h, and M Robert-Nicoud, and A Bensimon, and G Romeo
April 1987, Proceedings of the National Academy of Sciences of the United States of America,
K Monier, and X Michalet, and J Lamartine, and C Schurra, and F Heitzmann, and L Yin, and R Cinti, and B S Sylla, and M Creaven, and G Porta, and C Vourc'h, and M Robert-Nicoud, and A Bensimon, and G Romeo
January 2001, Cytogenetics and cell genetics,
K Monier, and X Michalet, and J Lamartine, and C Schurra, and F Heitzmann, and L Yin, and R Cinti, and B S Sylla, and M Creaven, and G Porta, and C Vourc'h, and M Robert-Nicoud, and A Bensimon, and G Romeo
July 1993, Genomics,
K Monier, and X Michalet, and J Lamartine, and C Schurra, and F Heitzmann, and L Yin, and R Cinti, and B S Sylla, and M Creaven, and G Porta, and C Vourc'h, and M Robert-Nicoud, and A Bensimon, and G Romeo
December 1989, Clinical genetics,
K Monier, and X Michalet, and J Lamartine, and C Schurra, and F Heitzmann, and L Yin, and R Cinti, and B S Sylla, and M Creaven, and G Porta, and C Vourc'h, and M Robert-Nicoud, and A Bensimon, and G Romeo
March 1997, Human genetics,
K Monier, and X Michalet, and J Lamartine, and C Schurra, and F Heitzmann, and L Yin, and R Cinti, and B S Sylla, and M Creaven, and G Porta, and C Vourc'h, and M Robert-Nicoud, and A Bensimon, and G Romeo
January 1999, Genetica,
K Monier, and X Michalet, and J Lamartine, and C Schurra, and F Heitzmann, and L Yin, and R Cinti, and B S Sylla, and M Creaven, and G Porta, and C Vourc'h, and M Robert-Nicoud, and A Bensimon, and G Romeo
December 1984, Tijdschrift voor kindergeneeskunde,
K Monier, and X Michalet, and J Lamartine, and C Schurra, and F Heitzmann, and L Yin, and R Cinti, and B S Sylla, and M Creaven, and G Porta, and C Vourc'h, and M Robert-Nicoud, and A Bensimon, and G Romeo
January 1996, Duodecim; laaketieteellinen aikakauskirja,
K Monier, and X Michalet, and J Lamartine, and C Schurra, and F Heitzmann, and L Yin, and R Cinti, and B S Sylla, and M Creaven, and G Porta, and C Vourc'h, and M Robert-Nicoud, and A Bensimon, and G Romeo
January 1989, Immunodeficiency reviews,
K Monier, and X Michalet, and J Lamartine, and C Schurra, and F Heitzmann, and L Yin, and R Cinti, and B S Sylla, and M Creaven, and G Porta, and C Vourc'h, and M Robert-Nicoud, and A Bensimon, and G Romeo
February 2002, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology,
Copied contents to your clipboard!